Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/200428
COMPARTIR / EXPORTAR:
SHARE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | NAMPT as a Dedifferentiation-Inducer Gene: NAD+ as Core Axis for Glioma Cancer Stem-Like Cells Maintenance |
Autor: | Lucena-Cacace, Antonio CSIC ORCID; Umeda, Masayuki; Navas, Lola E. CSIC; Carnero, Amancio CSIC ORCID | Palabras clave: | NAD NAMPT Glioma GSCs PARP SIRT TMZ GBM |
Fecha de publicación: | 2-may-2019 | Editor: | Frontiers Media | Citación: | Frontiers in Oncology 9: 292 (2019) | Resumen: | Glioma Cancer Stem-Like Cells (GSCs) are a small subset of CD133+ cells with self-renewal properties and capable of initiating new tumors contributing to Glioma progression, maintenance, hierarchy, and complexity. GSCs are highly resistant to chemo and radiotherapy. These cells are believed to be responsible for tumor relapses and patients' fatal outcome after developing a recurrent Glioblastoma (GBM) or High Grade Glioma (HGG). GSCs are cells under replicative stress with high demands on NAD+ supply to repair DNA, maintain self-renewal capacity and to induce tumor plasticity. NAD+ feeds Poly-ADP polymerases (PARP) and NAD+-dependent deacetylases (SIRTUINS) contributing to GSC phenotype. This energetic core axis is mainly controlled by the rate-limiting enzyme nicotinamide phosphoribosyltransferase (NAMPT), an important oncogene contributing to tumor dedifferentiation. Targeting GSCs depicts a new frontier in Glioma therapy; hence NAMPT could represent a key regulator for GSCs maintenance. Its inhibition may attenuate GSCs properties by decreasing NAD+ supply, consequently contributing to a better outcome together with current therapies for Glioma control. | Versión del editor: | https://doi.org/10.3389/fonc.2019.00292 | URI: | http://hdl.handle.net/10261/200428 | DOI: | 10.3389/fonc.2019.00292 | E-ISSN: | 2234-943X |
Aparece en las colecciones: | (IBIS) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
fonc-09-00292.pdf | 2,1 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
18
checked on 22-abr-2024
SCOPUSTM
Citations
17
checked on 24-may-2023
WEB OF SCIENCETM
Citations
19
checked on 07-may-2023
Page view(s)
122
checked on 27-abr-2024
Download(s)
143
checked on 27-abr-2024